SILO PHARMA, INC. Increase (Decrease) in Prepaid Expense and Other Assets
SILO PHARMA, INC. (SILO) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$88.48 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- SILO PHARMA, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$186.02K.
- SILO PHARMA, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $97.54K, a 18.93% decline year-over-year.
- SILO PHARMA, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$17.32K.
- SILO PHARMA, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $56.59K, a 54.62% decline year-over-year.
- SILO PHARMA, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$35.70K.
- SILO PHARMA, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$55.34K, a 177.06% decline from fiscal 2021.
- SILO PHARMA, INC. increase (decrease) in prepaid expense and other assets for fiscal 2021 was $71.80K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$186.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$88.48K 10-Q · filed 2026-08-13 | -$105.80K derived: sum of 3 quarters · filed 2026-08-13 | -$49.21K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | $97.54K 10-Q · filed 2026-05-14 | $80.22K derived: sum of 2 quarters · filed 2026-05-14 | $136.81K derived: sum of 3 quarters · filed 2026-05-14 | $95.68K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | -$17.32K derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-14 | $39.27K derived: sum of 2 quarters · filed 2026-04-14 | -$1.86K derived: sum of 3 quarters · filed 2026-08-13 | $118.46K POS AM · filed 2026-04-14 | |||
| 2025-09-30 | $56.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $15.46K derived: sum of 2 quarters · filed 2026-08-13 | $135.78K 10-Q · filed 2025-11-13 | -$81.18K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | -$41.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $79.19K 10-Q · filed 2026-08-13 | -$137.77K derived: sum of 3 quarters · filed 2026-08-13 | -$13.06K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | $120.31K 10-Q · filed 2026-05-14 | -$96.64K derived: sum of 2 quarters · filed 2026-05-14 | $28.06K derived: sum of 3 quarters · filed 2026-05-14 | $13.13K derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | -$216.96K derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-14 | -$92.25K derived: sum of 2 quarters · filed 2026-04-14 | -$107.19K derived: sum of 3 quarters · filed 2026-04-14 | $9.15K POS AM · filed 2026-04-14 | |||
| 2024-09-30 | $124.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $109.77K derived: sum of 2 quarters · filed 2025-11-13 | $226.10K 10-Q · filed 2025-11-13 | $160.71K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | -$14.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $101.40K 10-Q · filed 2025-08-13 | $36.00K derived: sum of 3 quarters · filed 2025-08-13 | $15.63K derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | $116.33K 10-Q · filed 2025-05-09 | $50.94K derived: sum of 2 quarters · filed 2025-05-09 | $30.57K derived: sum of 3 quarters · filed 2025-05-09 | -$20.13K derived: sum of 4 quarters · filed 2025-05-09 | |||
| 2023-12-31 | -$65.40K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$85.77K derived: sum of 2 quarters · filed 2025-03-28 | -$136.46K derived: sum of 3 quarters · filed 2025-03-28 | -$35.70K 10-K · filed 2025-03-28 | |||
| 2023-09-30 | -$20.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$71.07K derived: sum of 2 quarters · filed 2024-11-12 | $29.70K 10-Q · filed 2024-11-12 | -$312.85K derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | -$50.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $50.07K 10-Q · filed 2024-08-13 | $359.02K 10-Q · filed 2023-08-11 | -$292.48K derived: sum of 3 quarters · filed 2024-08-13 | |||
| 2023-03-31 | $100.77K 10-Q · filed 2024-05-13 | $287.21K 10-Q · filed 2023-05-12 | -$241.78K derived: sum of 2 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | -$342.55K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$55.34K 10-K · filed 2024-03-25 | $143.61K 10-Q · filed 2023-05-12 | ||||
| 2022-09-30 | $287.22K 10-Q · filed 2022-11-10 | ||||||
| 2021-12-31 | -$15.66K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $37.33K derived: sum of 2 quarters · filed 2023-03-24 | -$18.73K derived: sum of 3 quarters · filed 2023-03-24 | $71.80K 10-K · filed 2023-03-24 | |||
| 2021-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$3.07K derived: sum of 2 quarters · filed 2021-11-10 | $87.47K 10-Q · filed 2021-11-10 | ||||
| 2021-06-30 | -$56.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $34.47K 10-Q · filed 2021-08-13 | |||||
| 2021-03-31 | $90.54K 10-Q · filed 2021-05-17 | ||||||
| 2020-09-30 | $28.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $55.01K derived: sum of 2 quarters · filed 2021-11-10 | $68.05K 10-Q · filed 2021-11-10 | ||||
| 2020-06-30 | $26.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $39.41K 10-Q · filed 2021-08-13 | |||||
| 2020-03-31 | $13.03K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |